⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16272838 | 1.00 | — | — | |
| SCHEMBL28486930 | 0.84 | — | — | |
| SCHEMBL28486931 | 0.84 | — | — | |
| SCHEMBL29707222 | 0.84 | — | — | |
| SCHEMBL30565594 | 0.82 | GSR (0.64) | — | |
| Fluoride SCHEMBL28990878 | 0.82 | GSR (0.52) | — | |
| SCHEMBL29595628 | 0.82 | GSR (0.64) | — | |
| SCHEMBL29777438 | 0.77 | — | — | |
| SCHEMBL30759481 | 0.76 | — | — | |
| SCHEMBL27349738 | 0.76 | GSR (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12528838-B2 | Cyclic dominant negative competence stimulating peptide analogs and methods of treating Streptococcus pneumoniae infections | NEVADA RESEARCH & INNOVATION CORPORATION (US) | 2026-01-20 | — | — | US | disclosed |
| US-20230181678-A1 | NOVEL ANTIBACTERIAL PEPTIDE OR PEPTIDE ANALOG AND USE THEREOF | CAMP THERAPEUTICS INC. (KR) | 2023-06-15 | — | — | US | disclosed |
| US-20220227814-A1 | CYCLIC DOMINANT NEGATIVE COMPETENCE STIMULATING PEPTIDE ANALOGS AND METHODS OF TREATING STREPTOCOCCUS PNEUMONIAE INFECTIONS | BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIV OF NEVADA REN (US) | 2022-07-21 | — | — | US | disclosed |